Especially in solid tumours, CAR T cells suffer from exhaustion [43] and previous studies for B-ALL suggested that using a combination of TIGIT knockout with CD19-CAR NK cells improved their survival [21]. This evidence concerns the gene TIGIT and acute lymphoblastic leukemia.